Skip to main content

Table 3 Plasma lipid profiles of control subjects and patients whose HDL antioxidative capacity was measured in ultracentrifuged HDL (UCHDL) and apoBd plasma samples using the DHR assay

From: Comparing fluorescence-based cell-free assays for the assessment of antioxidative capacity of high-density lipoproteins

 

Controls

CHD

High SAA

Number

41

40

12

M/F, n

14/27

22/18

7/5

TC, mg/dL

174 ± 36

171 ± 41

193 ± 79

HDL-C, mg/dL

66 ± 18

53 ± 17**

72 ± 58

LDL-C, mg/dL

102 ± 27

99 ± 36

99 ± 44

TG, mg/dL

93 (68–122)

103 (77–153)

84 (62–133)

sd LDL-C, mg/dL

23 (17–29)

38 (23–45)

27 (17–32)

Apo A-I, mg/dL

172 ± 29

156 ± 33*

168 ± 78

  1. Data shown as mean ± SD or median (interquartile range). P value of the male-to-female ratio between the patients with cardiovascular disease and the control subjects is 0.059 analyzed by chi-squared test
  2. *p < 0.05, **p < 0.01 compared to controls
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X